hAGER
Nomenclature
C57BL/6JSmo-Agertm1(hAGER)Smoc
Cat. NO.
NM-HU-252005
Strain State
Repository Live
Gene Summary
Gene Symbol
Ager
Model Description
Validation Data

Fig.1 Detection of AGER expression in lung by RT-PCR. Mouse Ager mRNA (204 bp) was detectable only in wild-type C57BL/6 mice. Human AGER mRNA (169 bp) was detectable only in homozygous hAGER knockin mice but not in wild-type mice. Lung RNA was extracted from 6-week-old male wild-type C57BL/6 (WT)(n=3) and homozygous hAGER knockin mice (HO) (n=3), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.2 Detection of human AGER expression in serum of WT C57BL/6 mice and HO hAGER mice by ELISA. Human AGER was exclusively detectable in homozygous hAGER knockin mice. Serum were collected from wild-type C57BL/6 mice (n=3, male, 6 weeks old) and HO hAGER mice (n=3, male, 6 weeks old), and analyzed by ELISA with anti-hRAGE ELISA kit.
Abbr. HO, homozygous; WT, wild type; N.D, not detected.

Fig.3 Detection of human AGER expression in lung homogenate of WT C57BL/6 mice and HO hAGER mice by ELISA. Human AGER was exclusively detectable in homozygous hAGER knockin mice. Lung homogenate were collected from wild-type C57BL/6 mice (n=3, male, 6 weeks old) and HO hAGER mice (n=3, male, 6 weeks old), and analyzed by ELISA with anti-hRAGE ELISA kit.
Abbr. HO, homozygous; WT, wild type; N.D, not detected.

Fig.4 Detection of AGER expression in hAGER mice by WB. Human AGER was exclusively detectable in lung from HO hAGER mice with a human AGER antibody. The lung tissue lysates were collected from 6-week-old male wild-type C57BL/6 mice and 6-week-old male homozygous hAGER mice, and then analyzed by western blot with anti-AGER antibody.
Abbr. HO, homozygous; WT, wild type.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more